OZEM
Roundhill Investments - GLP-1 & Weight Loss ETF
1W: -1.3%
1M: -11.2%
3M: -13.2%
YTD: -11.9%
1Y: +25.4%
$30.13
-0.12 (-0.41%)
After Hours: $32.62 (+2.50, +8.29%)
Overview
Chart
Holdings
Changes
Technicals
Analysis
Peers
Institutions
Dark Pool
Short Interest
Weather
ETF-Level Metrics
AUM$39M
Holdings27
Top 10 Wt67.0%
Beta0.50
% Profitable46%
Coverage96%
Portfolio Valuation
P/E22.9
P/B5.5
P/S5.7
EV/EBITDA17.0
P/FCF34.4
PEG0.84
Profitability & Returns
Gross Margin72.1%
Net Margin24.9%
ROE25.5%
ROA14.6%
ROIC25.3%
Div Yield2.42%
Leverage & Liquidity
Debt/Equity0.28
Debt/Assets0.16
Net Debt/EBITDA-0.1x
Interest Cov26.1x
Current Ratio1.84
Quick Ratio1.42
Growth (YoY)
Revenue+27.0%
Net Income+39.7%
EPS+47.0%
FCF+33.6%
EBITDA+30.7%
Rev CAGR 3Y+42.6%
Quality Scores
Piotroski F5.8
Altman Z12.34
IS Quality73.3
IS Overall66.0
IS Value51.3
Median P/E13.8
Sector Breakdown
2 sectors| Sector | # Holdings | Total Weight % | Avg P/E |
|---|---|---|---|
| Healthcare | 25 | 99.6% | 10.7 |
| Other | 3 | 0.4% | — |
Smart Money Overlap
2 holdings with signals
Showing 28 of 28 holdings
· Page 1 of 1
| # | Name | Ticker | Weight % ▼ | Mkt Value | Shares | P/E | Mkt Cap | Sector |
|---|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | LLY | 16.03% | $8.1M | 9,003 | 38.2 | $829.8B | Healthcare |
| 2 | Novo Nordisk A/S | NVO | 13.28% | $6.7M | 183,834 | 9.9 | $160.2B | Healthcare |
| 3 | Pfizer Inc | PFE | 7.57% | $3.8M | 138,419 | 19.8 | $153.7B | Healthcare |
| 4 | Viking Therapeutics Inc | VKTX | 5.68% | $2.9M | 83,569 | -10.3 | $3.8B | Healthcare |
| 5 | Innovent Biologics Inc | 1801.HK | 4.88% | $2.5M | 242,500 | 84.3 | $147.1B | Healthcare |
| 6 | Ascletis Pharma Inc | 1672.HK | 4.67% | $2.4M | 1,133,000 | -55.4 | $17.8B | Healthcare |
| 7 | Hanmi Pharm Co Ltd | 128940.KS | 4.06% | $2.0M | 5,593 | 34.2 | $7.0T | Healthcare |
| 8 | Amgen Inc | AMGN | 4.04% | $2.0M | 5,762 | 24.4 | $188.0B | Healthcare |
| 9 | Roche Holding AG | ROP.SW | 4.03% | $2.0M | 5,146 | — | $248.7B | Healthcare |
| 10 | Zealand Pharma A/S | ZEAL.CO | 3.59% | $1.8M | 40,685 | 3.2 | $20.3B | Healthcare |
| 11 | AstraZeneca PLC | AZN | 3.57% | $1.8M | 9,819 | 28.4 | $146.1B | Healthcare |
| 12 | Chugai Pharmaceutical Co Ltd | 4519.T | 3.45% | $1.7M | 32,800 | 32.4 | $14.1T | Healthcare |
| 13 | Regeneron Pharmaceuticals Inc | REGN | 3.33% | $1.7M | 2,218 | 16.9 | $76.7B | Healthcare |
| 14 | Shanghai Fosun Pharmaceutical Group Co Ltd | 2196.HK | 3.16% | $1.6M | 662,500 | 20.5 | $74.2B | Healthcare |
| 15 | CSPC Pharmaceutical Group Ltd | 1093.HK | 2.69% | $1.4M | 1,298,000 | 25.5 | $106.1B | Healthcare |
| 16 | Gubra A/S | GUBRA.CO | 2.54% | $1.3M | 22,723 | 3.4 | $5.8B | Healthcare |
| 17 | United Laboratories International Holdings Ltd/The | 3933.HK | 2.37% | $1.2M | 954,000 | 12.9 | $20.0B | Healthcare |
| 18 | Structure Therapeutics Inc | GPCR | 2.33% | $1.2M | 25,378 | -19.3 | $2.6B | Healthcare |
| 19 | MBX Biosciences Inc | MBX | 1.92% | $969,329 | 34,264 | -12.0 | $957M | Healthcare |
| 20 | Gilead Sciences Inc | GILD | 1.91% | $964,046 | 7,043 | 19.6 | $166.7B | Healthcare |
| 21 | Shionogi & Co Ltd | 4507.T | 1.40% | $708,007 | 32,700 | 15.4 | $3.0T | Healthcare |
| 22 | Rhythm Pharmaceuticals Inc | RYTM | 1.38% | $693,120 | 8,463 | -25.8 | $5.2B | Healthcare |
| 23 | Biohaven Ltd | BHVN | 0.94% | $473,598 | 53,094 | -1.4 | $886M | Healthcare |
| 24 | First American Government Obligations Fund 12/01/2031 Swap | FGXXX | 0.76% | $382,033 | 382,033 | — | — | — |
| 25 | Corbus Pharmaceuticals Holdings Inc | CRBP | 0.41% | $204,490 | 22,131 | -1.5 | $109M | Healthcare |
| 26 | WaVe Life Sciences Ltd | WVE | 0.40% | $203,224 | 32,778 | -5.6 | $1.2B | Healthcare |
| 27 | Cash & Other Cash | — | 0.15% | $77,218 | 77,218 | — | — | — |
| 28 | SWISS FRANC Private | CHF | -0.54% | $-271,339 | -215,321 | — | — | — |